PhD Scientific Days 2026

Budapest, 16-18 June 2026

Poster Session 2.G - Pharmaceutical Sciences and Health Technologies

Separation of Plasma Extracellular Vesicles from Lipoproteins Using Density Gradient Ultracentrifugation and Size Exclusion Chromatography for Diagnostic Applications

Előadó neve

Kapui, Dóra, MSc

Neptune code

WLDFUH

Előadó munkahelye

Semmelweis University, Department of Pharmacology and Pharmacotherapy

Előadó telefonszáma

+36302528041

Előadó e-mail címe

kapui.dora.karolina@semmelweis.hu

Az előadás címe

Separation of Plasma Extracellular Vesicles from Lipoproteins Using Density Gradient Ultracentrifugation and Size Exclusion Chromatography for Diagnostic Applications

Szerző(k) neve és munkahelye

Dóra Kapui1, Szabolcs Hambalkó1, Yavuz Artuner1, Orsolya Szalai1, Sándor Zsidai1, Richárd Rácz1, Péter Ferdinandy2, Csenger Kovácsházi1, Zoltán Giricz2

1: Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest; Center for Pharmacology and Drug Research & Development, Semmelweis University, Budapest
2: Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest; Center for Pharmacology and Drug Research & Development, Semmelweis University, Budapest; Pharmahungary Group, Szeged

Bemutatás módja

Poszter

Szekció

Poster Session 2.G - Pharmaceutical Sciences and Health Technologies

Language of the presentation

English

Preferred session

Pharmaceutical Sciences and Health Technologies

Összefoglaló szövege

Introduction: Biomarkers in circulating extracellular vesicles (EVs) hold great potential for diagnostic applications. However, lipoproteins (LPs) share overlapping physical properties and molecular cargo with EVs, which can obscure EV-related signals. Therefore, efficient separation of EVs and LPs is needed to increase the sensitivity and specificity of EV-based diagnostics.
Aim: Our aim was to develop a method which separates EVs from LPs from human blood samples with optimal purity, yield and time efficiency, and to apply it in samples of patients suffering from acute myocardial infarction (AMI).
Methods: EVs were isolated from 1 mL human platelet-free plasma using iodixanol density gradient ultracentrifugation (DGUC) followed by size exclusion chromatography (SEC) with Sepharose 4 Fast Flow (4FF) columns. Isolates were analysed using nanoparticle tracking analysis (NTA), Qubit protein assay and Western blot (WB).
Results: WB analysis of iodixanol DGUC fractions revealed significant overlap between LP and EV markers, demonstrating the need of further purification steps. After 4FF SEC of the EV-rich fractions, WB analysis revealed the presence of EV markers, while mild LP contamination also presented. Application of the total workflow needed two experimental days for 6 samples. NTA revealed the presence of EV-sized nanoparticles in the isolates, with a significantly larger size than LP samples. NTA and Qubit protein assay revealed no significant difference in EV sample concentration between AMI and non-AMI patients.
Conclusion: Combined DGUC followed by 4FF SEC demonstrated acceptable EV-LP separation and processing time for plasma EV isolation. No significant difference was observed in plasma EV numbers of AMI and non-AMI patients. Molecular analysis of the EV samples may highlight EV-related differences, that can be used for the development of future diagnostic-prognostic applications.
Funding: The Ministry for Innovation and Technology of Hungary from the source of National Research, Development and Innovation Fund supported CK (EKÖP-2024-226 New National Excellence Program), ZG(K139105) and the project (2020-1.1.5-GYORSÍTÓSÁV-2021-00011). The project was further supported by the European Union (RRF-2.3.1-21-2022-00003). KD was supported by SE 250+ Excellence PhD Scholarship.

University

Semmelweis University

Supervisor

Zoltán Giricz

Publication of my abstract

I give consent to the publication of my abstract on the website of the congress.

phd.section.field

in doctoral studies after complex exam (PhD)

Kind

Szabad

Status

elfogadva

Accepted presentation method

poszter

Előadás fájl jóváhagyás

nem rendelkezett róla

Előadó

9087

Start

18:24

End

18:27